High Court orders preventing the harassment of staff by individuals and organisations involved in animal rights campaigning were today welcomed by the Association of the British Pharmaceutical Industry (ABPI).

 

‚ÄčThe orders were granted in the High Court to a number of UK-based Japanese pharmaceutical companies and their staff under the Protection from Harassment Act 1997. They relate to named individuals and organisations involved in animal rights campaigning to prevent them harassing the claimants' employees, families and those associated with them.

"Animal research is absolutely fundamental to the development of new medicines to help people suffering from illness and disease," said Andrew Curl, Deputy Director General of the ABPI.

"While those who oppose such work have every right to make their views known, many companies and staff have experienced quite unacceptable levels of harassment and attacks. I am delighted that the High Court has granted these orders preventing such activity."

Recent harassment targeted at some Japanese pharmaceutical companies and previously outlined in the High Court has included fire bombings, assaults on staff, intimidatory visits to staff homes, threatening, offensive and malicious letters and telephone calls, and criminal damage to individuals' property.

The companies who gained the injunction were:

  • ACT Tech UK Limited
  • Asahi Glass Fluoropolymers UK Limited
  • Daiichi Pharmaceuticals UK Limited
  • Eisai Limited
  • Eisai London Laboratories Limited
  • F2 Chemicals Limited
  • Sankyo Pharma UK Limited
  • Yamanouchi Pharma Limited
  • Yamanouchi UK Limited

For further information, please contact: ABPI Press Office 020 7747 1410

 
 
Print this page icon Print this page
 
Please choose the subject of your enquiry from the list below:
 
Code to enter for submitting the form
Enter the above code here:
Can't read? Try different words.